Beauty Health (SKIN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - The Beauty Health Company (SKIN) reported a revenue of $82.4 million for Q4 2025, reflecting a year-over-year decline of 1.3% and an EPS of -$0.06, an improvement from -$0.08 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $78.17 million by 5.42%, and the EPS also surpassed the consensus estimate of -$0.07 by 7.69% [1] Revenue Breakdown - Geographic Revenue in the Americas was $57.4 million, surpassing the average estimate of $53.65 million, with a year-over-year change of +0.5% [4] - Geographic Revenue in EMEA reached $18.8 million, exceeding the estimated $17.2 million, representing a +9.3% change year-over-year [4] - Geographic Revenue in Asia Pacific (APAC) was $6.1 million, below the average estimate of $7.49 million, showing a significant year-over-year decline of -33.7% [4] Sales Performance - Delivery Systems Net Sales amounted to $24.7 million, exceeding the estimated $20.85 million, but reflecting a year-over-year decline of -7.8% [4] - Consumables Net Sales were reported at $57.7 million, slightly above the average estimate of $57.34 million, indicating a year-over-year increase of +1.8% [4] Stock Performance - Shares of Beauty Health have returned +6.1% over the past month, contrasting with the Zacks S&P 500 composite's -2.3% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]